133 related articles for article (PubMed ID: 37004288)
1. Pathogenicity, transmissibility, and immunogenicity of recombinant H9N2 avian influenza viruses based on representative viruses of Southeast China.
Liu H; Chen Y; Li H; Yang L; Yang S; Luo X; Wang S; Chen JL; Yan S
Poult Sci; 2023 Jun; 102(6):102625. PubMed ID: 37004288
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
[TBL] [Abstract][Full Text] [Related]
3. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
4. Mutations of 127, 183 and 212 residues on the HA globular head affect the antigenicity, replication and pathogenicity of H9N2 avian influenza virus.
Fan M; Liang B; Zhao Y; Zhang Y; Liu Q; Tian M; Zheng Y; Xia H; Suzuki Y; Chen H; Ping J
Transbound Emerg Dis; 2022 Jul; 69(4):e659-e670. PubMed ID: 34724348
[TBL] [Abstract][Full Text] [Related]
5. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
6. Assessing the efficacy of a recombinant H9N2 avian influenza virus-inactivated vaccine.
Song CL; Liao ZH; Shen Y; Wang H; Lin WC; Li H; Chen WG; Xie QM
Poult Sci; 2020 Sep; 99(9):4334-4342. PubMed ID: 32867977
[TBL] [Abstract][Full Text] [Related]
7. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.
Song JM; Lee YJ; Jeong OM; Kang HM; Kim HR; Kwon JH; Kim JH; Seong BL; Kim YJ
Vet Microbiol; 2008 Aug; 130(3-4):268-76. PubMed ID: 18374520
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
[TBL] [Abstract][Full Text] [Related]
9. Generation of highly productive and mammalian nonpathogenic recombinant H9N2 avian influenza viruses by optimization of 3'end promoter and NS genome.
An SH; Lee CY; Choi JG; Lee YJ; Kim JH; Kwon HJ
Vet Microbiol; 2019 Jan; 228():213-218. PubMed ID: 30593370
[TBL] [Abstract][Full Text] [Related]
10. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
11. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
Sun Z; Wang Q; Li G; Li J; Chen S; Qin T; Ma H; Peng D; Liu X
Microbiol Spectr; 2021 Oct; 9(2):e0068721. PubMed ID: 34585985
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
15. Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity.
An SH; Hong SM; Song JH; Son SE; Lee CY; Choi KS; Kwon HJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240186
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken.
Yang W; Dai J; Liu J; Guo M; Liu X; Hu S; Gu M; Hu J; Hu Z; Gao R; Liu K; Chen Y; Liu X; Wang X
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632659
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism affecting route of transmission for H9N2 subtype AIV].
Shi HY; Liu XF
Wei Sheng Wu Xue Bao; 2006 Feb; 46(1):48-54. PubMed ID: 16579464
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of the airborne transmissibility of H9N2 avian influenza A viruses in chickens.
Zhong L; Wang X; Li Q; Liu D; Chen H; Zhao M; Gu X; He L; Liu X; Gu M; Peng D; Liu X
J Virol; 2014 Sep; 88(17):9568-78. PubMed ID: 24920791
[TBL] [Abstract][Full Text] [Related]
19. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.
Chen H; Subbarao K; Swayne D; Chen Q; Lu X; Katz J; Cox N; Matsuoka Y
Vaccine; 2003 May; 21(17-18):1974-9. PubMed ID: 12706686
[TBL] [Abstract][Full Text] [Related]
20. The PB1 gene from H9N2 avian influenza virus showed high compatibility and increased mutation rate after reassorting with a human H1N1 influenza virus.
Cui H; Che G; de Jong MCM; Li X; Liu Q; Yang J; Teng Q; Li Z; Beerens N
Virol J; 2022 Jan; 19(1):20. PubMed ID: 35078489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
